Sarah King

6.8k total citations
21 papers, 350 citations indexed

About

Sarah King is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Economics and Econometrics. According to data from OpenAlex, Sarah King has authored 21 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Physiology and 4 papers in Economics and Econometrics. Recurrent topics in Sarah King's work include Diabetes Management and Research (6 papers), Diabetes Management and Education (4 papers) and Dementia and Cognitive Impairment Research (4 papers). Sarah King is often cited by papers focused on Diabetes Management and Research (6 papers), Diabetes Management and Education (4 papers) and Dementia and Cognitive Impairment Research (4 papers). Sarah King collaborates with scholars based in United States, United Kingdom and Germany. Sarah King's co-authors include Urvi Desai, Oscar Patterson‐Lomba, Patrick Lefèbvre, Yao Wang, Martin Cloutier, Annette Urganus, Lori L. Davis, Jeffrey Schein, Christy R. Houle and Annie Guérin and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Sarah King

20 papers receiving 340 citations

Peers

Countries citing papers authored by Sarah King

Since Specialization

Citations

This map shows the geographic impact of Sarah King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah King more than expected).

Fields of papers citing papers by Sarah King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah King. The network helps show where Sarah King may publish in the future.

Co-authorship network of co-authors of Sarah King

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah King. A scholar is included among the top collaborators of Sarah King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah King. Sarah King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of the UK English Oxford cognitive screen-plus in sub-acute and chronic stroke survivors 2022 ·European Stroke Journal ·(unknown), (unknown), (unknown), (unknown), Sarah King, Nele Demeyere	11
2	Prevalence of post-traumatic stress disorder in the United States: a systematic literature review 2021 ·Current Medical Research and Opinion ·Jeffrey Schein, Christy R. Houle, Annette Urganus, Martin Cloutier, Oscar Patterson‐Lomba, Yao Wang, Sarah King, (unknown), Annie Guérin, Patrick Lefèbvre, Lori L. Davis	132
3	Toward a more comprehensive understanding of the emotional side of type 2 diabetes: A re-envisioning of the assessment of diabetes distress 2021 ·Journal of Diabetes and its Complications ·William H. Polonsky, Lawrence Fisher, Danielle Hessler, Urvi Desai, Sarah King, Magaly Perez‐Nieves	29
4	557-P: Patient and Caregiver Experiences during Severe Hypoglycemia: A Qualitative Assessment 2021 ·Diabetes ·Heather L. Stuckey, Urvi Desai, Sarah King, (unknown), (unknown), Noam Y. Kirson, Emily R. Hankosky, (unknown)	1
5	560-P: Reimagining the Assessment of Diabetes Distress in Type 2 Diabetes 2021 ·Diabetes ·William H. Polonsky, Lawrence Fisher, Danielle Hessler, Sarah King, Urvi Desai, Noam Y. Kirson, Magaly Perez‐Nieves	0
6	The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: “What am I going to do?” 2021 ·Diabetic Medicine ·Heather L. Stuckey, Urvi Desai, Sarah King, (unknown), (unknown), Noam Y. Kirson, Emily R. Hankosky, (unknown)	6
7	1282P Trial-based costs of all-cause adverse events in first-line therapy for advanced non-small cell lung cancer: Findings from CheckMate-227 2020 ·Annals of Oncology ·Solomon J. Lubinga, Sarah King, Keith A. Betts, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David D. Stenehjem	1
8	1316P Trial-based costs of all-cause adverse events in first-line therapy for advanced non-small cell lung cancer: Findings from CheckMate-9LA 2020 ·Annals of Oncology ·David D. Stenehjem, Solomon J. Lubinga, Sarah King, Keith A. Betts, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
9	Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes 2018 ·Diabetes Care ·Urvi Desai, Noam Y. Kirson, Jennifer Kim, Kamlesh Khunti, Sarah King, (unknown), (unknown), Phillip R. Hunt, Jayanti Mukherjee	43
10	Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related Angiomyolipomas 2017 ·Urology ·Elyse Swallow, Sarah King, Jinlin Song, (unknown), James Signorovitch, Zhimei Liu, (unknown), Michael Frost, Michael Kohrman, Bruce R. Korf, Darcy A. Krueger, Steven Sparagana	5
11	Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease 2017 ·Journal of Alzheimer s Disease ·Noam Y. Kirson, J. Scott Andrews, Urvi Desai, Sarah King, (unknown), Howard G. Birnbaum, Daniel Ball, Kristin Kahle‐Wrobleski	8
12	Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey 2017 ·Current Medical Research and Opinion ·Magaly Perez‐Nieves, Jasmina Ivanova, Irene Hadjiyianni, Chen Zhao, Dachuang Cao, (unknown), (unknown), Sarah King, Amy M. DeLozier, Howard G. Birnbaum, Mark Peyrot	14
13	Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population 2016 ·Therapeutic Advances in Gastroenterology ·(unknown), Peter G. Gibson, Peter J. Whorwell, John Kellow, Ann Yellowlees, (unknown), Mary Edwards, Sarah King, Hannah Wood, Julie Glanville	20
14	Reasons for Different Patterns of Basal Insulin Persistence after Initiation among People with Type 2 Diabetes Mellitus (T2DM) 2016 ·Canadian Journal of Diabetes ·Mark Peyrot, Jasmina Ivanova, (unknown), Sarah King, Howard G. Birnbaum, (unknown), Irene Hadjiyianni, (unknown), Dachuang Cao, (unknown), Magaly Perez‐Nieves	1
15	Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States population‐based survey 2016 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·J. Scott Andrews, Urvi Desai, Noam Y. Kirson, (unknown), (unknown), Sarah King, Howard G. Birnbaum, Adam Fleisher, Wenyu Ye, Kristin Kahle‐Wrobleski	18
16	A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union 2015 ·Nutrition Journal ·Julie Glanville, Sarah King, Francisco Guarner, Colin Hill, Mary Ellen Sanders	37
17	Budget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis 2015 ·Journal of Medical Economics ·Jasmina Ivanova, Sneha S. Kelkar, Sarah King, Howard G. Birnbaum, (unknown), (unknown), (unknown)	4
18	P4‐339: EXCESS COSTS ASSOCIATED WITH POSSIBLE MISDIAGNOSIS OF ALZHEIMER'S DISEASE AMONG PATIENTS WITH VASCULAR DEMENTIA IN A UK CPRD POPULATION 2014 ·Alzheimer s & Dementia ·Michael Happich, Noam Y. Kirson, Urvi Desai, Sarah King, Howard G. Birnbaum, David Price, Mark Belger, Craig Hunter, Alan Lenox‐Smith, Catherine Reed	1
19	Comparative efficacy of everolimus versus fulvestrant for hormone-receptor–positive (HR⁺) advanced breast cancer (ABC) following progression/recurrence after first-line treatment: A network meta-analysis. 2013 ·Journal of Clinical Oncology ·Thomas Bachelot, Guy Jérusalem, (unknown), Rachael McCool, Sarah King, Steven Duffy, Julie Glanville, Danielle Varley, Jie Zhang	1
20	Clinical outcome of diabetic patients after Palmaz-Schatz stent implantation 1998 ·Journal of the American College of Cardiology ·(unknown), Ziyad M.B. Ghazzal, (unknown), (unknown), Sarah King	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact